Batch selection based on CDP [Dissolution / BCS / IVIVC]

posted by dshah  – India/United Kingdom, 2022-03-02 20:17 (757 d 10:15 ago) – Posting: # 22819
Views: 1,205

Dear BE proff!
I believe there is no specific answer for your question. If drug is belonging to BCS class I/III- kindly follow the BCS based biowaiver guideline but for BCS II/IV- multiple factors can play a role.
The Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action by EMA can be useful for the choice in selecting media (emphasis on discrimination).
But the biorelvence can only be confirmed after the study outcome. F2 criteria alone are many times not useful.
The PIL can be useful for time point selection to capturing ADME but many times the Tmax, t1/2 can be slightly different in the research article.
Regards,
Divyen Shah

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
107 visitors (0 registered, 107 guests [including 4 identified bots]).
Forum time: 06:33 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5